New Zealand markets closed

Recordati Industria Chimica e Farmaceutica S.p.A. (0KBS.IL)

IOB - IOB Delayed price. Currency in EUR
Add to watchlist
48.98+0.32 (+0.66%)
As of 10:30AM BST. Market open.
Currency in EUR

Valuation measures4

Market cap (intra-day) 10.07B
Enterprise value 11.66B
Trailing P/E 26.15
Forward P/E 17.83
PEG ratio (5-yr expected) N/A
Price/sales (ttm)4.89
Price/book (mrq)5.95
Enterprise value/revenue 5.60
Enterprise value/EBITDA 16.46

Trading information

Stock price history

Beta (5Y monthly) 0.33
52-week change 321.00%
S&P500 52-week change 321.08%
52-week high 353.40
52-week low 340.62
50-day moving average 351.19
200-day moving average 347.55

Share statistics

Avg vol (3-month) 315.78k
Avg vol (10-day) 317.62k
Shares outstanding 5206M
Implied shares outstanding 6207.78M
Float 898.95M
% held by insiders 151.82%
% held by institutions 126.86%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 41.2
Forward annual dividend yield 42.71%
Trailing annual dividend rate 30.60
Trailing annual dividend yield 31.23%
5-year average dividend yield 42.46
Payout ratio 461.89%
Dividend date 3N/A
Ex-dividend date 422 May 2023
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)30 Jun 2023

Profitability

Profit margin 19.38%
Operating margin (ttm)30.08%

Management effectiveness

Return on assets (ttm)9.20%
Return on equity (ttm)25.04%

Income statement

Revenue (ttm)2.01B
Revenue per share (ttm)9.76
Quarterly revenue growth (yoy)4.20%
Gross profit (ttm)1.34B
EBITDA 722.6M
Net income avi to common (ttm)388.5M
Diluted EPS (ttm)1.86
Quarterly earnings growth (yoy)89.50%

Balance sheet

Total cash (mrq)528.57M
Total cash per share (mrq)2.57
Total debt (mrq)1.88B
Total debt/equity (mrq)116.65%
Current ratio (mrq)1.52
Book value per share (mrq)7.84

Cash flow statement

Operating cash flow (ttm)507.03M
Levered free cash flow (ttm)474.35M